Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

180 Life Sciences Corp. - Common Stock (NQ: ATNF )

1.330 -0.030 (-2.21%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 180 Life Sciences Corp. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Why Is Secoo (SECO) Stock Down 16% Today?
Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday. 
Via InvestorPlace
Why Is Immunic (IMUX) Stock Up 23% Today?
Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial. 
Via InvestorPlace
Why Is 180 Life Sciences (ATNF) Stock Up 30% Today?
180 Life Sciences (ATNF) stock is on the rise Wednesday despite a lack of news concerning the clinical-stage biotechnology company. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Summer Research Conference
Via Investor Brand Network
180 Life Sciences Announces Presentation at the Gordon Conference
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Update on Change of Status for Anti-TNF Frozen Shoulder Trial, Receives Patent Notification
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at all the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Application
From 180 Life Sciences Corp.
Via GlobeNewswire
180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial
From 180 Life Sciences Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Medical Advisory Board Chair Coauthors Review of Early Stage Dupuytren’s Disease Treatment
Via Investor Brand Network
180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Disease
From 180 Life Sciences Corp.
Via GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Engages Kinexum for Assistance in MAA Submission
Via Investor Brand Network
180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdom
From 180 Life Sciences Corp.
Via GlobeNewswire
Newman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)
From Newman Ferrara LLP
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Is Notified by NASDAQ Exchange of Full Compliance
Via Investor Brand Network
180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
From 180 Life Sciences Corp.
Via GlobeNewswire
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Review on Molecular Basis of Dupuytren’s Disease
Via Investor Brand Network
180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s Disease
From 180 Life Sciences Corp.
Via GlobeNewswire
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Wall Street Starts 2023 On Positive Note
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.